Menu
Contact Us
Subscribe
Menu

Never miss a post! Sign up for ML&P's newsletter.

Recent Posts

Transfer of Technology: New definition and stronger language needed

Medicines Law & Policy -
Statement by Medicines Law & Policy on Article 11, Technology Transfer Intergovernmental Negotiating Body on a Pandemic Accord (INB), Session 12 Delivered at the WHO on...

Getting to a meaningful agreement: ML&P’s opening statement to the 12th round of pandemic...

Medicines Law & Policy -
Thank you for giving us the opportunity to address the opening session of the INB12. We would like to make the following points: A pandemic agreement...

UN “Pact for the Future” intellectual property actions need revision to ensure innovation and...

Ellen 't Hoen -
UPDATE: From 22-23 September 2024, the Summit of the Future took place and adopted the Pact for the Future. The intellectual property paragraph of...

World Trade Organization Members Embark on Review of the TRIPS Agreement

Ellen 't Hoen -
The World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council will meet on 10-11 July. On the agenda is the review...

MSF’s Access Campaign is an invaluable actor in global health; shutting it down is...

Medicines Law & Policy -
On 20 June, STAT News reported that Médecins Sans Frontières (MSF) is closing down their Access Campaign, effective as of 31 December 2024. It...

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's newsletter.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.